Newsroom & Blog
Digital Transformation in Pathology / Why and how should pathologists keep up with AI?
The Region of Southern Denmark turns to Visiopharm to improve cancer-diagnostic turn-around times and precision
Digital Transformation in Pathology / Why and how is AI taking over the tissue image analysis field?
Digital Transformation in Pathology / Why and how should digital pathology be implemented into clinical practice?
Visiopharm’s AI-powered image analysis software selected to analyze the largest collection of human pathology specimens in the world
Visiopharm’s pioneering image analysis tools support thousands of scientists, pathologists, and image analysis experts in academic institutions, biopharmaceutical industry, and diagnostic centers. AI-based image analysis and tissue mining tools support research and drug development research worldwide, while CE-IVD APPs support primary diagnostics. With the most advanced and sophisticated artificial intelligence and deep learning, Visiopharm delivers tissue data mining tools, precision results, and workflows.
Visiopharm was founded in 2001 and is privately owned. The company operates internationally with over 900 licenses and countless users in more than 40 countries. The company headquarters are in Denmark’s Medicon Valley, with offices in Sweden, England, Germany, and the United States.